The global Drug Discovery Outsourcing market size is projected to grow from US$ 2844.3 million in 2023 to US$ 4352.4 million in 2030; it is expected to grow at a CAGR of 6.3% from 2024 to 2030.
Publisher' newest research report, the 鈥淒rug Discovery Outsourcing Industry Forecast鈥� looks at past sales and reviews total world Drug Discovery Outsourcing sales in 2023, providing a comprehensive analysis by region and market sector of projected Drug Discovery Outsourcing sales for 2024 through 2030. With Drug Discovery Outsourcing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Drug Discovery Outsourcing industry.
This Insight Report provides a comprehensive analysis of the global Drug Discovery Outsourcing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Drug Discovery Outsourcing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Drug Discovery Outsourcing market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Drug Discovery Outsourcing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Drug Discovery Outsourcing.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report presents a comprehensive overview, market shares, and growth opportunities of Drug Discovery Outsourcing market by product type, application, key players and key regions and countries.
Segmentation by type
Small Molecules
Biologics
Segmentation by application
Hospitals and Clinics
Pharmaceutical Companies
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Charles River Laboratories
Thermo Fisher Scientific
DomaineX
Evotec A.G.
GenScript
Abbott Laboratories
GVkBiosciences
Agilent Technologies
Shimadzu
Bio-Rad
PerkinElmer
AMRI Global
LabCorp
WuXi AppTec
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Drug Discovery Outsourcing 麻豆原创 Size 2019-2030
2.1.2 Drug Discovery Outsourcing 麻豆原创 Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Drug Discovery Outsourcing Segment by Type
2.2.1 Small Molecules
2.2.2 Biologics
2.3 Drug Discovery Outsourcing 麻豆原创 Size by Type
2.3.1 Drug Discovery Outsourcing 麻豆原创 Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Drug Discovery Outsourcing 麻豆原创 Size 麻豆原创 Share by Type (2019-2024)
2.4 Drug Discovery Outsourcing Segment by Application
2.4.1 Hospitals and Clinics
2.4.2 Pharmaceutical Companies
2.4.3 Others
2.5 Drug Discovery Outsourcing 麻豆原创 Size by Application
2.5.1 Drug Discovery Outsourcing 麻豆原创 Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Drug Discovery Outsourcing 麻豆原创 Size 麻豆原创 Share by Application (2019-2024)
3 Drug Discovery Outsourcing 麻豆原创 Size by Player
3.1 Drug Discovery Outsourcing 麻豆原创 Size 麻豆原创 Share by Players
3.1.1 Global Drug Discovery Outsourcing Revenue by Players (2019-2024)
3.1.2 Global Drug Discovery Outsourcing Revenue 麻豆原创 Share by Players (2019-2024)
3.2 Global Drug Discovery Outsourcing Key Players Head office and Products Offered
3.3 麻豆原创 Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Drug Discovery Outsourcing by Regions
4.1 Drug Discovery Outsourcing 麻豆原创 Size by Regions (2019-2024)
4.2 Americas Drug Discovery Outsourcing 麻豆原创 Size Growth (2019-2024)
4.3 APAC Drug Discovery Outsourcing 麻豆原创 Size Growth (2019-2024)
4.4 Europe Drug Discovery Outsourcing 麻豆原创 Size Growth (2019-2024)
4.5 Middle East & Africa Drug Discovery Outsourcing 麻豆原创 Size Growth (2019-2024)
5 Americas
5.1 Americas Drug Discovery Outsourcing 麻豆原创 Size by Country (2019-2024)
5.2 Americas Drug Discovery Outsourcing 麻豆原创 Size by Type (2019-2024)
5.3 Americas Drug Discovery Outsourcing 麻豆原创 Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Drug Discovery Outsourcing 麻豆原创 Size by Region (2019-2024)
6.2 APAC Drug Discovery Outsourcing 麻豆原创 Size by Type (2019-2024)
6.3 APAC Drug Discovery Outsourcing 麻豆原创 Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Drug Discovery Outsourcing by Country (2019-2024)
7.2 Europe Drug Discovery Outsourcing 麻豆原创 Size by Type (2019-2024)
7.3 Europe Drug Discovery Outsourcing 麻豆原创 Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Drug Discovery Outsourcing by Region (2019-2024)
8.2 Middle East & Africa Drug Discovery Outsourcing 麻豆原创 Size by Type (2019-2024)
8.3 Middle East & Africa Drug Discovery Outsourcing 麻豆原创 Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Global Drug Discovery Outsourcing 麻豆原创 Forecast
10.1 Global Drug Discovery Outsourcing Forecast by Regions (2025-2030)
10.1.1 Global Drug Discovery Outsourcing Forecast by Regions (2025-2030)
10.1.2 Americas Drug Discovery Outsourcing Forecast
10.1.3 APAC Drug Discovery Outsourcing Forecast
10.1.4 Europe Drug Discovery Outsourcing Forecast
10.1.5 Middle East & Africa Drug Discovery Outsourcing Forecast
10.2 Americas Drug Discovery Outsourcing Forecast by Country (2025-2030)
10.2.1 United States Drug Discovery Outsourcing 麻豆原创 Forecast
10.2.2 Canada Drug Discovery Outsourcing 麻豆原创 Forecast
10.2.3 Mexico Drug Discovery Outsourcing 麻豆原创 Forecast
10.2.4 Brazil Drug Discovery Outsourcing 麻豆原创 Forecast
10.3 APAC Drug Discovery Outsourcing Forecast by Region (2025-2030)
10.3.1 China Drug Discovery Outsourcing 麻豆原创 Forecast
10.3.2 Japan Drug Discovery Outsourcing 麻豆原创 Forecast
10.3.3 Korea Drug Discovery Outsourcing 麻豆原创 Forecast
10.3.4 Southeast Asia Drug Discovery Outsourcing 麻豆原创 Forecast
10.3.5 India Drug Discovery Outsourcing 麻豆原创 Forecast
10.3.6 Australia Drug Discovery Outsourcing 麻豆原创 Forecast
10.4 Europe Drug Discovery Outsourcing Forecast by Country (2025-2030)
10.4.1 Germany Drug Discovery Outsourcing 麻豆原创 Forecast
10.4.2 France Drug Discovery Outsourcing 麻豆原创 Forecast
10.4.3 UK Drug Discovery Outsourcing 麻豆原创 Forecast
10.4.4 Italy Drug Discovery Outsourcing 麻豆原创 Forecast
10.4.5 Russia Drug Discovery Outsourcing 麻豆原创 Forecast
10.5 Middle East & Africa Drug Discovery Outsourcing Forecast by Region (2025-2030)
10.5.1 Egypt Drug Discovery Outsourcing 麻豆原创 Forecast
10.5.2 South Africa Drug Discovery Outsourcing 麻豆原创 Forecast
10.5.3 Israel Drug Discovery Outsourcing 麻豆原创 Forecast
10.5.4 Turkey Drug Discovery Outsourcing 麻豆原创 Forecast
10.5.5 GCC Countries Drug Discovery Outsourcing 麻豆原创 Forecast
10.6 Global Drug Discovery Outsourcing Forecast by Type (2025-2030)
10.7 Global Drug Discovery Outsourcing Forecast by Application (2025-2030)
11 Key Players Analysis
11.1 Charles River Laboratories
11.1.1 Charles River Laboratories Company Information
11.1.2 Charles River Laboratories Drug Discovery Outsourcing Product Offered
11.1.3 Charles River Laboratories Drug Discovery Outsourcing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.1.4 Charles River Laboratories Main Business Overview
11.1.5 Charles River Laboratories Latest Developments
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Information
11.2.2 Thermo Fisher Scientific Drug Discovery Outsourcing Product Offered
11.2.3 Thermo Fisher Scientific Drug Discovery Outsourcing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.2.4 Thermo Fisher Scientific Main Business Overview
11.2.5 Thermo Fisher Scientific Latest Developments
11.3 DomaineX
11.3.1 DomaineX Company Information
11.3.2 DomaineX Drug Discovery Outsourcing Product Offered
11.3.3 DomaineX Drug Discovery Outsourcing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.3.4 DomaineX Main Business Overview
11.3.5 DomaineX Latest Developments
11.4 Evotec A.G.
11.4.1 Evotec A.G. Company Information
11.4.2 Evotec A.G. Drug Discovery Outsourcing Product Offered
11.4.3 Evotec A.G. Drug Discovery Outsourcing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.4.4 Evotec A.G. Main Business Overview
11.4.5 Evotec A.G. Latest Developments
11.5 GenScript
11.5.1 GenScript Company Information
11.5.2 GenScript Drug Discovery Outsourcing Product Offered
11.5.3 GenScript Drug Discovery Outsourcing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.5.4 GenScript Main Business Overview
11.5.5 GenScript Latest Developments
11.6 Abbott Laboratories
11.6.1 Abbott Laboratories Company Information
11.6.2 Abbott Laboratories Drug Discovery Outsourcing Product Offered
11.6.3 Abbott Laboratories Drug Discovery Outsourcing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.6.4 Abbott Laboratories Main Business Overview
11.6.5 Abbott Laboratories Latest Developments
11.7 GVkBiosciences
11.7.1 GVkBiosciences Company Information
11.7.2 GVkBiosciences Drug Discovery Outsourcing Product Offered
11.7.3 GVkBiosciences Drug Discovery Outsourcing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.7.4 GVkBiosciences Main Business Overview
11.7.5 GVkBiosciences Latest Developments
11.8 Agilent Technologies
11.8.1 Agilent Technologies Company Information
11.8.2 Agilent Technologies Drug Discovery Outsourcing Product Offered
11.8.3 Agilent Technologies Drug Discovery Outsourcing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.8.4 Agilent Technologies Main Business Overview
11.8.5 Agilent Technologies Latest Developments
11.9 Shimadzu
11.9.1 Shimadzu Company Information
11.9.2 Shimadzu Drug Discovery Outsourcing Product Offered
11.9.3 Shimadzu Drug Discovery Outsourcing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.9.4 Shimadzu Main Business Overview
11.9.5 Shimadzu Latest Developments
11.10 Bio-Rad
11.10.1 Bio-Rad Company Information
11.10.2 Bio-Rad Drug Discovery Outsourcing Product Offered
11.10.3 Bio-Rad Drug Discovery Outsourcing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.10.4 Bio-Rad Main Business Overview
11.10.5 Bio-Rad Latest Developments
11.11 PerkinElmer
11.11.1 PerkinElmer Company Information
11.11.2 PerkinElmer Drug Discovery Outsourcing Product Offered
11.11.3 PerkinElmer Drug Discovery Outsourcing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.11.4 PerkinElmer Main Business Overview
11.11.5 PerkinElmer Latest Developments
11.12 AMRI Global
11.12.1 AMRI Global Company Information
11.12.2 AMRI Global Drug Discovery Outsourcing Product Offered
11.12.3 AMRI Global Drug Discovery Outsourcing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.12.4 AMRI Global Main Business Overview
11.12.5 AMRI Global Latest Developments
11.13 LabCorp
11.13.1 LabCorp Company Information
11.13.2 LabCorp Drug Discovery Outsourcing Product Offered
11.13.3 LabCorp Drug Discovery Outsourcing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.13.4 LabCorp Main Business Overview
11.13.5 LabCorp Latest Developments
11.14 WuXi AppTec
11.14.1 WuXi AppTec Company Information
11.14.2 WuXi AppTec Drug Discovery Outsourcing Product Offered
11.14.3 WuXi AppTec Drug Discovery Outsourcing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.14.4 WuXi AppTec Main Business Overview
11.14.5 WuXi AppTec Latest Developments
12 Research Findings and Conclusion
听
听
*If Applicable.
